Brain scans to understand hidradenitis suppurativa
Part of Infections, Skin clinical trials.
This study uses MRI brain scans to see if brain activity differs in people with hidradenitis suppurativa (a painful skin condition) compared to healthy volunteers. It also tracks how treatment affects the brain over 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old and have hidradenitis suppurativa.
- You must be right-handed.
- You cannot be currently taking certain medications for depression or seizure prevention.
- You must be willing to have photos taken of the affected skin.
- You cannot have other major skin diseases or psychiatric conditions.
- You must be able to lie still in an MRI machine.
- If you are in the treatment part, you must be scheduled to start a biologic or small-molecule therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people with hidradenitis suppurativa (a skin condition causing painful lumps) to better understand the condition and improve care worldwide.
This trial looks at a type of immune cell (MAIT cells) in people with hidradenitis suppurativa (a skin condition causing painful bumps). It aims to understand how these cells work and how they relate to treatments like adalimumab, secukinumab, or bimekizumab. You may be able to join if you have moderate-to-severe HS and are about to start one of these treatments.
This study looks at the real-life impact of hidradenitis suppurativa (HS), a skin condition, on people like you. You'll answer questions about your symptoms and daily life to help researchers understand the burden of HS.
This trial tests an investigational medicine, SPY072, for adults with moderate to severe hidradenitis suppurativa (also known as HS), a skin condition that causes painful lumps and sores. If you join, you'll help see if this treatment is safe and effective.
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.